Problems finding your way around may be earliest sign of Alzheimer's disease

by Gerry Everding,Washington University in St. LouisA bird's-eye view of a virtual maze layout used in a study of how cognitive mapping and wayfinding skills are compromised in early stages

Updated on: February 28,2024 11

Problems finding your way around may be earliest sign of Alzheimer's disease

by Gerry Everding,Washington University in St. LouisA bird's-eye view of a virtual maze layout used in a study of how cognitive mapping and wayfinding skills are compromised in early stages

Updated on:February 28,2024 11

Testing for inflammatory proteins can help diagnose progression of Alzheimer's disease

by Modesta (Maud) Alobawone,Rutgers UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainTesting for some inflammatory proteins associated with the nervous and

Updated on: June 20,2024 6

Testing for inflammatory proteins can help diagnose progression of Alzheimer's disease

by Modesta (Maud) Alobawone,Rutgers UniversityPET scan of a human brain with Alzheimer's disease. Credit: public domainTesting for some inflammatory proteins associated with the nervous and

Updated on:June 20,2024 6

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024 20

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024 20

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024 0

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on: March 02,2024 19

Study reports on contributions to white matter injury in Alzheimer's disease

by Impact Journals LLCA vicious cycle generating WM injury driven by mixed vascular and ADNC in the aging human white matter. Diagnostic challenges for IHC and neuroimaging. Credit:Aging(2

Updated on:March 02,2024 19

Multivariate analysis improves on cognitive testing in Alzheimer's disease

by Future Science GroupMultivariate analysis of cognitive tests in Alzheimer's disease identifies five distinct groups of Alzheimer's disease patients, and suggests that multivitamins might sl

Updated on: March 07,2024 12

Multivariate analysis improves on cognitive testing in Alzheimer's disease

by Future Science GroupMultivariate analysis of cognitive tests in Alzheimer's disease identifies five distinct groups of Alzheimer's disease patients, and suggests that multivitamins might sl

Updated on:March 07,2024 12

Estrogen may offer protection against delirium

by Cedars-Sinai Medical CenterOophorectomy (OVX) and urinary tract infection (UTI)-mediated changes in cleaved caspase-3 (CC3). (A) A schematic of design of a preliminary experiment examining the

Updated on: February 05,2024 15

Estrogen may offer protection against delirium

by Cedars-Sinai Medical CenterOophorectomy (OVX) and urinary tract infection (UTI)-mediated changes in cleaved caspase-3 (CC3). (A) A schematic of design of a preliminary experiment examining the

Updated on:February 05,2024 15

Most seniors with dementia live at home, despite pain, anxiety, poor health

by University of California, San FranciscoCredit: CC0 Public DomainContrary to popular belief, most older Americans with advancing dementia remain in their own homes—many until they die. But a ne

Updated on: May 13,2024 8

Most seniors with dementia live at home, despite pain, anxiety, poor health

by University of California, San FranciscoCredit: CC0 Public DomainContrary to popular belief, most older Americans with advancing dementia remain in their own homes—many until they die. But a ne

Updated on:May 13,2024 8

A health care device for tracking chronic diabetic wounds

by KAISTSchematic illustrations and diagrams of real-time wound monitoring systems. Credit:Advanced Healthcare Materials(2023). DOI: 10.1002/adhm.202302797A KAIST research team has develop

Updated on: March 19,2024 14

A health care device for tracking chronic diabetic wounds

by KAISTSchematic illustrations and diagrams of real-time wound monitoring systems. Credit:Advanced Healthcare Materials(2023). DOI: 10.1002/adhm.202302797A KAIST research team has develop

Updated on:March 19,2024 14

Hospital patients with dementia and other causes of confusion 'have worse outcomes'

by University of StirlingProfessor Emma Reynish, Chair in Dementia Studies at the University of Stirling. Credit: University of StirlingHospital patients with dementia and other causes of confusi

Updated on: March 09,2024 16

Hospital patients with dementia and other causes of confusion 'have worse outcomes'

by University of StirlingProfessor Emma Reynish, Chair in Dementia Studies at the University of Stirling. Credit: University of StirlingHospital patients with dementia and other causes of confusi

Updated on:March 09,2024 16

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on: February 26,2024 17

Alzheimer's-disease-related proteases control axonal guidance by regulating growth cone dynamics

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.BACE1 is the major drug target for Alzheimer's

Updated on:February 26,2024 17

Children's headaches and mental health worsened during pandemic

by Children's National HospitalCredit: Unsplash/CC0 Public DomainSince the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent

Updated on: February 18,2024 15

Children's headaches and mental health worsened during pandemic

by Children's National HospitalCredit: Unsplash/CC0 Public DomainSince the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent

Updated on:February 18,2024 15